CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3

Mol Cancer. 2022 Jan 18;21(1):23. doi: 10.1186/s12943-022-01497-w.

Abstract

Background: Functions of CircMET (hsa_circ_0082002) which is a circular RNA and derived from MET gene remain understood incompletely. In the present study, Xp11.2 translocation/NONO-TFE3 fusion renal cell carcinoma (NONO-TFE3 tRCC) with up-regulated CircMET was employed to investigate its mechanism in cancer progression and post-transcriptional regulation.

Methods: FISH and real-time PCR were performed to explore the expression and localization circMET in NONO-TFE3 tRCC tissues and cells. The functions of circMET in tRCC were investigated by proliferation analysis, EdU staining, colony and sphere formation assay. The regulatory mechanisms among circMET, CDKN2A and SMAD3 were investigated by luciferase assay, RNA immunoprecipitation, RNA pulldown and targeted RNA demethylation system.

Results: The expression of circMET was upregulated by NONO-TFE3 fusion in NONO-TFE3 tRCC tissues and cells, and overexpression of circMET significantly promoted the growth of NONO-TFE3 tRCC. Mechanistic studies revealed that circMET was delivered to cytosol by YTHDC1 in N6-methyladenosine (m6A)-depend manner. CircMET enhances mRNA decay of CDKN2A by direct interaction and recruitment of YTHDF2. Meanwhile, circMET competitively absorbed miR-1197 and prevented those from SMAD3 mRNA.

Conclusions: CircMET promotes the development of NONO-TFE3 tRCC, and the regulation to both CDKN2A and SMAD3 of circMET was revealed. CircMET has the potential to serve as a novel target for the molecular therapy of NONO-TFE3 tRCC as well as the other cancer with high-expressing circMET.

Keywords: CDKN2A; NONO-TFE3; SMAD3; circMET; m6A modification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / metabolism
  • Cell Proliferation
  • Chromatin Immunoprecipitation Sequencing
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • DNA-Binding Proteins / metabolism
  • Disease Models, Animal
  • Gene Expression Regulation, Neoplastic*
  • Heterografts
  • Humans
  • Methylation
  • Mice
  • Models, Biological
  • Protein Binding
  • Proto-Oncogene Proteins c-met / genetics*
  • Proto-Oncogene Proteins c-met / metabolism
  • RNA Processing, Post-Transcriptional
  • RNA Stability*
  • RNA Transport
  • RNA, Circular*
  • RNA, Messenger / genetics
  • Smad3 Protein / metabolism*
  • Translocation, Genetic

Substances

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA-Binding Proteins
  • RNA, Circular
  • RNA, Messenger
  • SMAD3 protein, human
  • Smad3 Protein
  • TFE3 protein, human
  • MET protein, human
  • Proto-Oncogene Proteins c-met